Capital Advisors Ltd’s Viemed Healthcare VMD Stock Holding History

Capital Advisors Ltd’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	89	–	–	﹤0.01%	1319
2026 Q1	$1K	Hold	89	–	–	﹤0.01%	1309
2025 Q4	$1K	Hold	89	–	–	﹤0.01%	1297
2025 Q3	$1K	Hold	89	–	–	﹤0.01%	1307
2025 Q2	$1K	Hold	89	–	–	﹤0.01%	1288
2025 Q1	$1K	Hold	89	–	–	﹤0.01%	1285
2024 Q4	$1K	Hold	89	–	–	﹤0.01%	1320
2024 Q3	$1K	Hold	89	–	–	﹤0.01%	1310
2024 Q2	$1K	Hold	89	–	–	﹤0.01%	1310
2024 Q1	$1K	Hold	89	–	–	﹤0.01%	1289
2023 Q4	$1K	Hold	89	–	–	﹤0.01%	1236
2023 Q3	$1K	Hold	89	–	–	﹤0.01%	1230
2023 Q2	$1K	Hold	89	–	–	﹤0.01%	1233
2023 Q1	$1K	Hold	89	–	–	﹤0.01%	1132
2022 Q4	$1K	Hold	89	–	–	﹤0.01%	1115
2022 Q3	$1K	Hold	89	–	–	﹤0.01%	1143
2022 Q2	$0	Hold	89	–	–	﹤0.01%	1343
2022 Q1	$0	Buy	+89	New	+$413	﹤0.01%	1220

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Capital Advisors Ltd's VMD Position: Q2 2026 in Review

Capital Advisors Ltd held its Viemed Healthcare (VMD) position steady in Q2 2026 at 89 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

Capital Advisors Ltd first reported a position in VMD in Q1 2022 and has held it in 18 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Capital Advisors Ltd held 89 shares of Viemed Healthcare worth $1K as of Q2 2026.
Capital Advisors Ltd left its Viemed Healthcare share count unchanged in Q2 2026.
Viemed Healthcare made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1319 holding.
Capital Advisors Ltd first reported a position in Viemed Healthcare in Q1 2022 and has held it in 18 quarters since.
167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.